Concepedia

Publication | Closed Access

The Effectiveness of Early Treatment with “Second-Line” Antirheumatic Drugs

DOI

474

Citations

0

References

1996

Year

Agnes van der Heide, Johannes W G Jacobs, J W Bijlsma, A H M Heurkens, C van Booma-Frankfort, M. J. van der Veen, H. C. M. Haanen, D Hofman
Annals of Internal Medicine

Abstract

Early introduction of SAARDs may be more beneficial than delayed introduction for patients with recently diagnosed rheumatoid arthritis.